Takeda Pharmaceutical Co. Ltd. - Other Operating Expenses

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Other-Operating-Expenses" stands at 248.71 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2017.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 247.50 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 247.50 Billion Japanese Yens.
The 5 year change is 244.23 Billion Japanese Yens.
The 10 year change is -624.37 Billion Japanese Yens.

The Serie's long term average value is 311.17 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -62.46 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2020, to it's latest available value, on 09/30/2025, is +252.56 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2012, to it's latest available value, on 09/30/2025, is -679.89 Billion.